CRISPR/Cas9 technology generated a C to G change at position 183 (c.183C>G) resulting in a cysteine to tryptophan substitution at residue 61 (p.Cys61Trp). This is a variant identified in a patient with oculocutanous albinism. (J:314755)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count